Methylene blue and Alzheimer’s disease
This review discusses the potential of methylene blue (MB) as a therapeutic agent for Alzheimer’s disease (AD). MB has been shown to reduce amyloid plaque and neurofibrillary tangle formation, improve mitochondrial function, and modulate neurotransmitter systems, including cholinergic, serotonergic, and glutamatergic pathways. These combined effects suggest that MB could offer
June 26, 2025
No Comments